BioSpace News Archive

Massive Bio and CureMatch have joined forces in a transformative partnership aimed at revolutionizing cancer treatment.

Medcura Inc., proudly announces the appointment of Jacob Rodman to its Board of Directors.

hC Bioscience, a pioneering biotech company dedicated to advancing tRNA-based therapeutics, has appointed Heather Hirsch, Ph.D., as the Senior Vice President of Translational Science and Cancer Biology.

Harmony Biosciences Holdings, Inc. today announced that it will report second quarter 2023 financial results on Tuesday, August 1, 2023, before the open of the U.S. financial markets.

The Pancreatic Cancer Action Network proudly announces the addition of fourteen new members to its Scientific and Medical Advisory Board, as well as the elevation of current SMAB members Eileen M. O’Reilly, MD, of Memorial Sloan Kettering Cancer Center and Gregory Beatty, MD, PhD to the roles of Chair and Vice Chair, respectively.

Fulgent Genetics, Inc. today announced that it will release its second quarter 2023 financial results before the market opens on Friday, August 4, 2023.

This month, Agile Therapeutics, Inc. (NASDAQ:AGRX) announced partnerships with FPA Women’s Health and vitaCare Prescription Services that will expand access to Twirla (levonorgestrel and ethinyl estradiol) transdermal system, its low-dose weekly birth control patch.

Revolo Biotherapeutics today announced additional data from its proof of concept, 2-week, 3-dose, Phase 2a clinical trial evaluating the efficacy, safety, and tolerability of the company’s immune-resetting drug, ‘1104, in adults with active eosinophilic esophagitis (EoE).

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2023 after the market close on Tuesday, August 1, 2023.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its second quarter 2023 financial results on Monday, July 31st, 2023, after the market closes.